‏إظهار الرسائل ذات التسميات CCMB. إظهار كافة الرسائل
‏إظهار الرسائل ذات التسميات CCMB. إظهار كافة الرسائل

India to have Slaughter-Free Meat Cultivated in Lab By 2020 with a Centre to Support Related Startups

The size and demand of the meat industry is growing rapidly and according to estimates, meat consumption in India is going to rise with the rise in population in the coming years. Anticipating the same, the Maharashtra state government and the Indian arm of US-based NGO Good Food Institute (GFI) have had signed an MoU, in February this year, to set up a Centre for Excellence in Cellular Agriculture in Jalna city, Aurangabad Division of Maharashtra, in a bid to promote cell-based meat production in India.

Cell-based meat cultivation involves growing animal cells in a laboratory rather than slaughtering animals and therefore the meat cultivated in labs is also called as 'slaughter-free' or 'clean meat' and is considered as nutritionally equivalent to conventional animal meat.

The centre will look into developing methods to cultivate stem cells from tissue samples of sheep, to produce mutton.

Set up by Institute of Chemical Technology (ICT), Mumbai, the upcoming centre is touted as world’s first research centre focused on research and development in the cell-based meat category.

In its first phase, a lab is expected to come up in Mumbai next year. The second phase, a greenfield project, is expected to come up on 203 acres of land owned by ICT in Jalna by 2021, said GFI India Managing Director Varun Deshpande, to Indian Express.

Additionally, the upcoming centre will also provide facilities for related startups to investigate and create Proofs-of-Concept (PoCs). It will also conduct contract research for relevant private industries and startups and create curriculum and training for the sector.

[caption id="attachment_130386" align="alignleft" width="770"] Image Credit - nrn.com[/caption]

Washington-based GFI will offer expertise and guidance in setting up the lab through its network of scientists. "The concept of cell-based meat is still in an early stage in the country. However, the size and demand of the meat industry is growing rapidly. It is estimated that in the coming years, meat consumption in India is going to rise with the rise in population," said Deshpande.

Good Food Institute (GFI) is a nonprofit that promotes plant-based meat, dairy, and eggs as well as clean meat (also known as cultured meat and cell-based meat), as alternatives to the products of conventional animal agriculture. GFI targets scientists, policymakers, and entrepreneurs to promote plant-based products and cellular agriculture.

The current Indian meat industry is valued at an estimated Us $2.585 Billion ( ~ Rs 20,000 crore). Cell-based meat companies in Netherlands, Israel and Japan are receiving support from their governments, while regulatory authorities in America USA are in the process of developing a framework for cell-based meet.

In an another similar cell-based meat initiative, Hyderabad's Centre for Cellular and Molecular Biology (CCMB), in collaboration with the National Research Centre on Meat (NRCM), has also initiated research aimed at producing cell-based meat and Department of Biotechnology (DBT), government of India, has even agreed to fund the project with an initial grant of Rs 4.6 crore.

CCMB too has collaborated with GFI for same.

CCMB operates under the aegis of the Council of Scientific and Industrial Research (CSIR), Government of India, and is a designated "Center of Excellence" by the Global Molecular and Cell Biology Network, UNESCO.

Additionally, CCMB has also signed an agreement with Humane Society International India to launch a ‘Centre for Predictive Human Model Systems;, whiche will help enable shift in scientific research by focusing on new methodologies instead of animal models. This centre aims to stop use animals in research purposes. The alternative testing method would be to test the human cells and convert them into organoids (an artificially grown mass of cells or tissue that resembles an organ).

Source - The Hindu, Business Line, Indian Express, Food Navigator-Asia

[Top Featured Image - Techspot.com]

Meet 4 Biotech Startups Selected For iHUB Incubator of CCMB

Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) made waves in the Indian startup world last year when it announced about opening an Innovation Hub (iHUB@CCMB) in its medical biotechnology complex there. CCMB, which is a research establishment of the Council of Scientific and Industrial Research (CSIR), set up the Innovation Hub with an aim of engaging with the industry and translating its own research into reality.

After the launch, the iHUB is in the news once again for selecting four biology startup companies- Bioartis, Virupaksha Life Sciences, Theranosis and Oncosimis. This is for the very first time that the Innovation hub has signed up four biology startup companies. All the selected four have already exchanged a licence agreement with the CCMB to incubate their startups at CCMB's Hyderabad-based iHUB.

A press release announcing the selection reveals that the CCMB has put in extra efforts in providing state-of-the-art facilities at iHUB so that any biology startup could make optimum use of those facilities as "plug and play" mode and have these at their disposal.

According to a statement given by CCMB Director Rakesh Mishra, the basic idea behind setting up iHUB was that any biology startup in India shouldn't have to look beyond iHuB for facilities and that each of these startups should be provided with a fair chance at becoming a success by executing their business plans.

He also added that the Innovation hub hosts a number of activities like scientist-industry interactions and training programmes on how-to produce industry-ready human resource that would specifically prove beneficial to the biotech industry.

Here's some more information about the selected 4 biology startups:

1) Oncosimis Bitotech Private Limited



Incorporated on 05 December, 2016 by Lokireddy Chandra Mohan Reddy and Lokireddy Sudarsanareddy, this Telangana-based biology startup plans to establish their innovative processes in the production of biosimilars and develop a novel/innovative process to prepare a number of cancer drugs.

2) Virupaksha Life Sciences



Incorporated in November 2016 by its founder M Bala Subba Reddy, Virupaksha Life sciences plans to utilise iHUB facilities to develop novel molecules for diabetes.

3) Theranosis Lifesciences Pvt Ltd



Incorporated in February 2016 by founders Shibi Chakravarthy and Balakrishna Venugopal Nambur, Theranosis Lifesciences Pvt Ltd is a Biotech R&D startup, which is on a mission to enable personalized cancer therapy by harnessing the power of Asia’s largest biobank of patient derived tumor tissues and India’s BioIT S/W skills to develop and deliver novel theranostic products for the global market and clinical diagnostic services to the Indian market.

The startup's vision is to build on the recent advances being made in the medical technology field and give birth to a sustainable, viable and scalable product-oriented Biotech R&D company with a goal to deliver niche "in vitro diagnostics" for enabling personalised cancer care.

4) Bioartis Life Sciences Private Limited



Founded by Sunanda Arvapally, Jatin Arrvapalli, Deepti Naseer and Nasaruddin Khaja in July 2014, Bioartis Life Sciences Private Limited is focused on optimizing and validating novel diagnosis methods for diseases of animal and marine origin. It also plans to develop diagnostic kits for such marine diseases.

According to the Press Release, all the selected four biology startups are expected to start their activities at iHub very soon.

[Top Image - Shutterstock]

Market Reports

Market Report & Surveys
IndianWeb2.com © all rights reserved